A Pharmacodynamic Study of Dapoxetine Concomitantly Administered in Participants Taking Terazosin
Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the pharmacodynamics (the actions or effects a drug
has on the body), pharmacokinetics (blood levels), safety, and tolerability of dapoxetine 60
mg when concomitantly administered in participants taking terazosin.